Oryzon Genomics SA (ORY) — Cash Flow Reinvestment Rate
Latest as of December 2015:
0.17x
Oryzon Genomics SA (ORY) has a Cash Flow Reinvestment Rate of 0.17x as of December 2015, reinvesting €87.70K (capex €87.70K ) from operating cash flow of €523.10K. See Oryzon Genomics SA (ORY) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.17x
(Capex + Investments) / Operating CF
Total Reinvested
€87.70K
Capex + Investments
Operating Cash Flow
€523.10K
EUR
Capital Expenditures
€87.70K
EUR
Oryzon Genomics SA Cash Flow Reinvestment Rate (2013–2015)
Historical reinvestment intensity for Oryzon Genomics SA across 3 annual periods. For the full cash flow conversion analysis, see ORY cash flow conversion.
Annual Cash Flow Reinvestment Rate for Oryzon Genomics SA (2013–2015)
Year-by-year capital reinvestment analysis for Oryzon Genomics SA. See Oryzon Genomics SA (ORY) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 6.74x | €3.53 Million | €523.14K | €87.65K | ▲ +2244.9% |
| 2014 | 0.29x | €3.49 Million | €12.13 Million | €47.00K | ▼ 0.0% |
| 2013 | 0.29x | €3.49 Million | €12.13 Million | €47.30K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow